Aithal GP - Search Results

1

Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis.

Ratziu V, Bedossa P, Francque SM, Larrey D, Aithal GP, Serfaty L, Voiculescu M, Preotescu L, Nevens F, De Lédinghen V, Kirchner GI, Trunecka P, Ryder SD, Day CP, Takeda J, Traudtner K. Ratziu V, et al. Among authors: aithal gp. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1724-30.e5. doi: 10.1016/j.cgh.2014.01.040. Epub 2014 Feb 12. Clin Gastroenterol Hepatol. 2014. PMID: 24530600 Clinical Trial.

2

CYP2C9 polymorphism and warfarin dose requirements.

Daly AK, Day CP, Aithal GP. Daly AK, et al. Among authors: aithal gp. Br J Clin Pharmacol. 2002 Apr;53(4):408-9. doi: 10.1046/j.1365-2125.2002.01572_6.x. Br J Clin Pharmacol. 2002. PMID: 11966680 Free PMC article. No abstract available.

3

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.

Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP. Aithal GP, et al. Hepatology. 2004 May;39(5):1430-40. doi: 10.1002/hep.20205. Hepatology. 2004. PMID: 15122773

4

Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.

Bullock RE, Zaitoun AM, Aithal GP, Ryder SD, Beckingham IJ, Lobo DN. Bullock RE, et al. Among authors: aithal gp. J Hepatol. 2004 Oct;41(4):685-6. doi: 10.1016/j.jhep.2004.05.008. J Hepatol. 2004. PMID: 15464253 No abstract available.

5

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CP. Daly AK, et al. Among authors: aithal gp. Gastroenterology. 2007 Jan;132(1):272-81. doi: 10.1053/j.gastro.2006.11.023. Epub 2006 Nov 17. Gastroenterology. 2007. PMID: 17241877

6

Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

Aithal GP, Day CP. Aithal GP, et al. Clin Liver Dis. 2007 Aug;11(3):563-75, vi-vii. doi: 10.1016/j.cld.2007.06.004. Clin Liver Dis. 2007. PMID: 17723920 Review.

7

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM. Guha IN, et al. Among authors: aithal gp. Hepatology. 2008 Feb;47(2):455-60. doi: 10.1002/hep.21984. Hepatology. 2008. PMID: 18038452

8

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.

Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, Austin AS, Freeman JG, Morgan L, Webber J. Aithal GP, et al. Gastroenterology. 2008 Oct;135(4):1176-84. doi: 10.1053/j.gastro.2008.06.047. Epub 2008 Jun 25. Gastroenterology. 2008. PMID: 18718471 Clinical Trial.

9

Fast-food hyper-alimentation and exercise restriction in healthy subjects.

Johnston RD, Aithal GP, Ryder SD, MacDonald IA. Johnston RD, et al. Among authors: aithal gp. Gut. 2009 Mar;58(3):469-70; author reply 470. Gut. 2009. PMID: 19211862 No abstract available.

10

A role for the pregnane X receptor in flucloxacillin-induced liver injury.

Andrews E, Armstrong M, Tugwood J, Swan D, Glaves P, Pirmohamed M, Aithal GP, Wright MC, Day CP, Daly AK. Andrews E, et al. Among authors: aithal gp. Hepatology. 2010 May;51(5):1656-64. doi: 10.1002/hep.23549. Hepatology. 2010. PMID: 20222094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters